The world's leading journal on infectious diseases. Clinical ID, public health, microbiology, and everything in-between. Official publication of @IDSAinfo
Safety of short-course weekly rifapentine and isoniazid (3HP) for TB preventive treatment at conception and during first trimester in women living with HIV: a secondary analysis of WHIP3TB trial
β Just Accepted
βοΈ @Auruminstitute
π https://t.co/UyVIuVyCkW
A randomized clinical trial to compare moxiFloxAcin veRsus aziTHromycin for the trEatment of MycoplaSma geniTalium: the FARTHEST Study
β Just Accepted
π https://t.co/HeUhyx4Gel
Three Months of Weekly Rifapentine and Isoniazid Versus Four Months of Daily Rifampicin for Tuberculosis Infection: A Randomized Controlled Trial
β Just Accepted
π https://t.co/l6DuynBLyH
The Best of Both Worlds: How Combining a Large Language Model and a Rule-Based Algorithm Makes CAUTI Surveillance More Efficient
β Just Accepted
https://t.co/IDcfibFbk4
Health-Related Quality of Life in Well-treated People With HIV and Comparators Over an 8-year Period: A Longitudinal Analysis From the Prospective AGEhIV Cohort Study
β Just Accepted
https://t.co/ye5DTG0nKY
Is One All We Really Need? Reply to Lorenz et al Regarding Shorter Duration of Benzathine Penicillin G Therapy for Late or Unknown Duration Syphilis
β Just Accepted
π https://t.co/uc4Smdpqdq
Serological Response After Shorter Durations of Therapy for Syphilis of Late Latent or Unknown Duration: What Does It Mean?
β Just Accepted
π https://t.co/Po3U6dz955
Concerns regarding the probabilistic sensitivity analysis in the cost-effectiveness of universal hepatitis delta virus testing
β Just Accepted
π https://t.co/cYgIjG4XHA
Field performance and acceptability of the hepatitis B core-related antigen rapid diagnostic test (HBcrAg-RDT) for detecting high viral load among pregnant women in The Gambia (PROTECT-B)
β Just Accepted
π https://t.co/GdtWCNYwGG